Landscape Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Landscape Capital Management’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-38,501	Closed	-$389K	–	987
2022 Q4	$389K	Hold	38,501	–	–	0.06%	318
2022 Q3	$382K	Buy	38,501 +500	+1%	+$4.94K	0.05%	357
2022 Q2	$376K	Buy	38,001 +22,034	+138%	+$216K	0.05%	339
2022 Q1	$157K	Hold	15,967	–	–	0.02%	715
2021 Q4	$157K	Hold	15,967	–	–	0.02%	626
2021 Q3	$156K	Buy	+15,967	New	+$155K	0.02%	597

Landscape Capital Management's BIOT Position: Q1 2023 in Review

Landscape Capital Management sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 38,501 shares — an estimated $389K sold.

Landscape Capital Management first reported a position in BIOT in Q3 2021 and held it in 6 quarters. The position peaked at $389K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Landscape Capital Management reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Landscape Capital Management sold 38,501 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $389K.
Landscape Capital Management first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
Landscape Capital Management's Biotech Acquisition Company Class A Ordinary Shares position peaked at $389K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.